Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company carries out wholesale trade in pharmaceutical products.
| Line item | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|
| 5,009 | 968 | 5,199 | +1.9% | |
| 70 | 59 | 133 | +38.1% | |
| TOTAL ASSETS | 5,079 | 1,027 | 5,332 | +2.5% |
| 578 | 467 | 1,911 | +81.9% | |
| Total Non-Current Liabilities | 0 | 0 | 0 | |
| TOTAL LIABILITIES | 578 | 467 | 1,911 | +81.9% |
| Total Equity | 4,501 | 560 | 3,420 | -12.8% |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | |
| Debt analysis | ||||
| Total Debt | 0 | 0 | 0 | |
| Cash & Equivalents | 4,311 | 174 | 1,557 | -39.9% |
| Net Debt | 4,311 | 174 | 1,557 | -39.9% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →